company background image
CVS logo

CVS Health NYSE:CVS Stock Report

Last Price

US$77.57

Market Cap

US$97.6b

7D

2.1%

1Y

3.5%

Updated

18 Mar, 2024

Data

Company Financials +

Narratives

Beta

Narratives bring a range of perspectives from our community.

CVS Health Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for CVS Health
Historical stock prices
Current Share PriceUS$77.57
52 Week HighUS$83.25
52 Week LowUS$64.41
Beta0.50
1 Month Change0.61%
3 Month Change1.72%
1 Year Change3.45%
3 Year Change5.58%
5 Year Change41.16%
Change since IPO11,715.29%

Recent News & Updates

CVS Health: Better Times Likely Ahead

Mar 12

CVS Health: Lower Guidance But Risk/Reward Remains Attractive

Feb 15

Recent updates

CVS Health: Better Times Likely Ahead

Mar 12

CVS Health: Lower Guidance But Risk/Reward Remains Attractive

Feb 15

CVS Health FY23 Earnings: Downgrades Inevitable, Long Term Outlook In The Balance

Feb 07

CVS Health: Back In The Buy Column

Jan 21

CVS Health (NYSE:CVS) Has Announced That It Will Be Increasing Its Dividend To $0.665

Jan 17
CVS Health (NYSE:CVS) Has Announced That It Will Be Increasing Its Dividend To $0.665

CVS Health: Shares Remain Modestly Undervalued, Robust Free Cash Flow, Technical Strength

Jan 08

CVS Health (NYSE:CVS) Is Paying Out A Larger Dividend Than Last Year

Jan 03
CVS Health (NYSE:CVS) Is Paying Out A Larger Dividend Than Last Year

CVS Health: Risk/Reward Highly Skewed To The Upside

Dec 15

CVS Health (NYSE:CVS) Is Increasing Its Dividend To $0.665

Dec 13
CVS Health (NYSE:CVS) Is Increasing Its Dividend To $0.665

We Think CVS Health (NYSE:CVS) Is Taking Some Risk With Its Debt

Dec 08
We Think CVS Health (NYSE:CVS) Is Taking Some Risk With Its Debt

CVS Health: A Good Fit To Buffett's 10x Pretax Rule

Dec 07

CVS Health: Not One Dividend Cut In 30 Years And A Good Upside

Nov 27

CVS Health: All Eyes On December Investor Day

Nov 21

CVS Health Ahead Of Q3 Earnings: Making The Pivot Toward Value-Based Care Work

Oct 26

CVS Health: 'Only' A Fair Company For A Wonderful Price?

Oct 20

CVS Health Offers Recession-Resistant Growth With Transformation

Oct 05

CVS Stock: The Risk-Reward Is In A Better Place

Sep 18

CVS Health: Share Price Suffers As Business Transformation Flounders

Aug 25

Is CVS Health (NYSE:CVS) A Risky Investment?

Aug 25
Is CVS Health (NYSE:CVS) A Risky Investment?

Walgreens Vs. CVS: I Call A Tie Now Based On A Peter Lynch Evaluation

Aug 16

CVS Health: Second Quarter Was Only Decent, But Integration Is On Track

Aug 03

CVS Health: Undervalued Long-Term Gem

Jul 21

CVS Health: Buy The Complexity Discount

Jul 13

Shareholder Returns

CVSUS HealthcareUS Market
7D2.1%0.3%-0.1%
1Y3.5%6.1%28.4%

Return vs Industry: CVS underperformed the US Healthcare industry which returned 6.1% over the past year.

Return vs Market: CVS underperformed the US Market which returned 28.4% over the past year.

Price Volatility

Is CVS's price volatile compared to industry and market?
CVS volatility
CVS Average Weekly Movement2.9%
Healthcare Industry Average Movement7.3%
Market Average Movement6.1%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.0%

Stable Share Price: CVS has not had significant price volatility in the past 3 months.

Volatility Over Time: CVS's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1996259,500Karen Lynchhttps://www.cvshealth.com

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

CVS Health Corporation Fundamentals Summary

How do CVS Health's earnings and revenue compare to its market cap?
CVS fundamental statistics
Market capUS$97.62b
Earnings (TTM)US$8.34b
Revenue (TTM)US$356.62b

11.7x

P/E Ratio

0.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CVS income statement (TTM)
RevenueUS$356.62b
Cost of RevenueUS$303.35b
Gross ProfitUS$53.28b
Other ExpensesUS$44.93b
EarningsUS$8.34b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)6.63
Gross Margin14.94%
Net Profit Margin2.34%
Debt/Equity Ratio78.6%

How did CVS perform over the long term?

See historical performance and comparison

Dividends

3.4%

Current Dividend Yield

37%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.